Club Mediterranee Ad (CLMDY) 5.1000 $CLMDY Reports:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Club Mediterranee Ad (CLMDY) 5.1000 $CLMDY

Reports: China tycoon appears at event after disappearance
By JOE McDONALD - AP - Mon Dec 14, 1:15AM CST
BEIJING (AP) — The chairman of the Chinese conglomerate that owns Club Med and whose company said he was assisting an official investigation after he disappeared for a day last week, appeared Monday at a corporate meeting, two newspapers reported.
MIG: 8.64 (+0.01)


Prominent tycoon entangled in Chinese investigation
By JOE McDONALD - AP - Fri Dec 11, 9:31AM CST
BEIJING (AP) — One of China's top entrepreneurs, the chairman of the Fosun conglomerate that owns Club Med and other businesses in Europe and the U.S., is assisting Chinese authorities with an investigation, his company said, a possible sign that an anti-corruption campaign is widening beyond state companies.
MIG: 8.64 (+0.01)

The Future of Travel Intermediaries in France to 2018
M2 - Tue Jan 06, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/8dgpww/the_future_of) has announced the addition of the "The Future of Travel Intermediaries in France to 2018: Market Profile" report to their offering. "The Future of Travel Intermediaries in France to 2018: Market Profile" is the result of extensive research on the travel and tourism industry covering the travel intermediaries market in France. It provides detailed analysis on key trends and issues, market size and forecasts, key performance indicators and competitive landscape in the French airlines market. The report also includes an overview of the French travel and tourism industry covering key trends, barriers to tourism and tourist attractions with a detailed SWOT analysis of the tourism industry in France. Review and forecast data for tourism demand factors and market indicators has also been included in the report. This report also provides an overview of the leading companies in the travel intermediaries market in France. Key Topics Covered: 1 Introduction 2 The Travel And Tourism Sector In Context 3 Travel Intermediaries 4 Company Profiles - Travel Intermediaries 5 Market Data Analysis 6 Appendix Companies Mentioned - Arts Et Vie Paris - Carlson Wagonlit Travels France - Club Mediterranee SA - TUI Travel France - Thomas Cook SAS For more information visit http://www.researchandmarkets.com/research/8d..._future_of

CPA:18 - Global Acquires $72 Million Long-Term Net-Leased Mauritius Resort Hotel
PR Newswire - Tue Jan 06, 6:30AM CST
W. P. Carey Inc. (NYSE: WPC), a global net-lease REIT specializing in corporate sale-leaseback, build-to-suit construction financing and the acquisition of single-tenant net-lease properties, announced today that CPA®:18 - Global, one of its managed non-traded REITs, has acquired a 266-room resort hotel, La Plantation d'Albion Club Med, located in Albion, Mauritius, for approximately $72 million (EUR 59 million).
WPC: 66.10 (+0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Stewart Title's Leadership Changes Enhance Real Estate Services

Updated Category News Views 302

Stewart Title's Leadership Changes Enhance Real Estate Services Stewart Title is making significant leadership changes as part of its strategic approach to improve service offerings and expertise in the real estate transaction process. The company is recognized for its comprehensive services and deep expertise in residential and commercial title insurance, along with...

Continue Reading
Thoughtworks Joins DCfH2 Framework to Enhance Healthcare Solutions

Updated Category News Views 141

Thoughtworks Joins the DCfH2 Framework In a groundbreaking development, Thoughtworks has secured its position as a key supplier in the Digital Capability for Health 2 (DCfH2) framework. This prestigious framework is designed specifically for the UK Government's Public Health and Social Care programs. By integrating strategy, design, and engineering, Thoughtworks aims to...

Continue Reading
Simmons First National Corporation Sets Q3 2024 Earnings Call

Updated Category News Views 49

Simmons First National Corporation got set to drop its Q3 2024 earnings back in October, right before the market opened. Traders were buzzing because, honestly, these numbers can shake up the floor like an unexpected market quake. A well-established financial holding company with a long history of dividends is great on paper, but those digits tell the real...

Continue Reading
Alma Bank to Acquire American Community Bank

Updated Category News Views 22

Banking Shake-Up: Alma Bank's Bold Move Well, here we go again with another banking merger trying to make waves in the New York area. Alma Bank is swallowing up American Community Bank in an effort to broaden its horizons, specifically across New York and New Jersey. No big surprise there—these two have been eyeing potential synergies in complementary markets for a...

Continue Reading
Elastic N.V. Surpasses Expectations with Strong Q1 Results

Updated Category News Views 100

Elastic N.V. Reports Impressive Q1 Earnings Elastic N.V. (NYSE: ESTC) has recently experienced a significant boost in its market performance, attributed to their better-than-expected first-quarter results. The company's quarterly earnings reached 60 cents per share, exceeding the analyst consensus estimate of 42 cents per share. Furthermore, Elastic showcased robust...

Continue Reading